Impact of BacT/Alert® VIRTUO®, BioFire® Blood Culture Identification 2-BCID2 and REVEAL® (bioMérieux) on the Optimization of Antibiotic Therapy for Gram-negative Bacteremia in the ICU
Clinical trial NCT05741424 · COMPLETED
Trial details
- NCT number
- NCT05741424
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2024-05-06
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.